PROFFERED PAPERS Monday, March 19   —  1:00 PM   —  CC Ballroom D Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... Section D - Pulmonary Pathology Chaired by: Sanjay Mukhopadhyay and James Suh Time Title and Authors Itinerary Planner 1:00 Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma and Invasive Pulmonary Adenocarcinoma – Evaluation of Interobserver Agreement in 294 Nodules with Survival Analysis (1972) JM Boland, JA Wampfler, P Yang, MC Aubry, M de Andrade, ES Yi - Mayo Clinic, Rochester, MN Add 1:15 Assessment of Invasion Degree of Small Sized Lung Cancer Using Intra-Operative Frozen Section (2018) N Motoi, W Hamanaka, T Oba, S Karita, H Ono, Y Saito, S Sato, K Inamura, S Okumura, Y Ishikawa - Japanese Foundation for Cancer Research, JFCR, Tokyo, Japan; The Cancer Institute Hospital of JFCR, Tokyo, Japan Add 1:30 Molecular Versus Histopathologic Staging of Lung Adenocarcinoma with Multiple Tumor Nodules (1965) NT Beaubier, MM Mansukhani, AC Borczuk - Columbia University Medical Center, New York, NY Add 1:45 Met Activation Is Associated with Unique Clinicopathologic and Molecular Features in Lung Adenocarcinoma (2046) LM Sholl, AJ Iafrate, M-T Wu, A Ligon, PA Janne, DC Christiani, M Loda, LR Chirieac - Brigham and Women´s Hospital, Boston; Massachusetts General Hospital, Boston; Kaohsiung Medical University, Kaohsiung, Taiwan; Dana Farber Cancer Institute, Boston Add 2:00 Resolving the Controversy on EGFR/KRAS Mutations in Pulmonary Squamous Cell Carcinoma Via Comprehensive Pathologic Assessment Incorporating Immunohistochemistry (2032) N Rekhtman, PK Paik, ME Arcila, LJ Tafe, GR Oxnard, AL Moreira, TD William, MF Zakowski, KG Mark, M Ladanyi - Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY; Dartmouth Hitchcock Medical Center, Lebanon, NH; Dana-Farber Cancer Institute, Boston, MA Add 2:15 Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors (1986) F Goeke, A Franzen, R Mennon, V Scheble, D Goltz, R Kirsten, D Boehm, W Vogel, A Schroeck, S Perner - University Hospital Bonn, Bonn, Germany; University Hospital Tuebingen, Tuebingen, Germany Add 2:30 Gene Expression Profiling of Lung Neuroendocrine (NE) Tumors Reveals Gene Clusters Correlated with Central Versus Peripheral Location for Carcinoids (2052) H Wang, MS Roh, R Shen, J Zheng, G Sica, C Stock, I Sarkaria, M Pietanza, N Rekhtman, A Iyoda, V Rusch, W Travis - MSKCC, New York; Dong-A University College of Medicine, Busan, Korea; Emory University, Georgia; Kitasato University, Kanagawa, Japan; Weill Cornell Medical College, New York, NY Add 2:45 Massively Parallel Sequencing in NSCLC: Comparison to Traditional Hot Spot Analysis for Selection of Approved and Novel Targeted Therapies (2036) J Ross, A Parker, M Jarosz, S Downing, R Yelensky, D Lipson, P Stephens, G Palmer, M Cronin, C Sheehan - Albany Medical College, Albany, NY; Foundation Medicine Inc., Cambridge, MA Add 3:00 RECESS, EXHIBITS, POSTER SESSION II   4:30 NATHAN KAUFMAN TIMELY TOPICS LECTURE Bogdan Czerniak, MD, PhD The Cancer Genome: A Step Towards Personalized Therapy CC Ballroom A-D Add